BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/26/2018 9:00:43 AM | Browse: 1458 | Download: 3055
Publication Name World Journal of Clinical Cases
Manuscript ID 40026
Country China
Received
2018-06-08 01:27
Peer-Review Started
2018-06-08 12:00
First Decision by Editorial Office Director
2018-07-03 16:00
Return for Revision
2018-07-13 01:11
Revised
2018-08-22 07:51
Publication Fee Transferred
Second Decision by Editor
2018-08-27 09:23
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2018-08-28 02:53
Articles in Press
2018-08-28 02:53
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-09-24 03:55
Publish the Manuscript Online
2018-09-26 09:00
ISSN 2307-8960 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, Research & Experimental
Manuscript Type Retrospective Study
Article Title Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study
Manuscript Source Unsolicited Manuscript
All Author List Deng-Feng Ren, Fang-Chao Zheng, Jun-Hui Zhao, Guo-Shuang Shen, Raees Ahmad, Shui-Sheng Zhang, Yu Zhang, Jie Kan, Li Dong, Zi-Yi Wang, Fu-Xing Zhao and Jiu-Da Zhao
ORCID
Author(s) ORCID Number
Deng-Feng Ren http://orcid.org/0000000245449528
Fang-Chao Zheng http://orcid.org/000000022640544X
Jun-Hui Zhao http://orcid.org/000000025443853X
Guo-Shuang Shen http://orcid.org/0000000293818658
Raees Ahmad http://orcid.org/0000000299755213
Shui-Sheng Zhang http://orcid.org/0000000166607495
Yu Zhang http://orcid.org/0000000283838364
Jie Kan http://orcid.org/0000000172590474
Li Dong http://orcid.org/0000000232927834
Zi-Yi Wang http://orcid.org/0000000232617457
Fu-Xing Zhao http://orcid.org/0000000309765184
Jiu-Da Zhao http://orcid.org/0000000212668943
Funding Agency and Grant Number
Funding Agency Grant Number
the Thousand Talents of Program of High-end Innovation of Qinghai Province in China
the Clinical Oncology Medical Center of Qinghai Province in China 2018-SF-113
Corresponding Author Jiu-Da Zhao, MD, Professor, Department of Medical Oncology, Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University, No. 29, Tongren Road, Xining 810000, Qinghai Province, China. jiudazhao@126.com
Key Words Gastric cancer; D2 gastrectomy; Adjuvant chemotherapy; S-1; Oxaliplatin; Capecitabine
Core Tip Based on the therapeutic efficacy of both S-1 mono-therapy and oxaliplatin plus capecitabine regimen in ACTS-gastric cancer (GC) and CLASSIC study, we conducted the multi-institutional research using propensity score-matched analysis to evaluate whether patients after D2 resection benefit from adjuvant chemotherapy with S-1 plus oxaliplatin (SOX). Here, we firstly report that SOX adjuvant chemotherapy, compared with surgery alone, significantly improves disease-free survival and overall survival in stage ⅠB-ⅢC GC patients undergoing D2 resection with accepted side effects.
Publish Date 2018-09-26 09:00
Citation Ren DF, Zheng FC, Zhao JH, Shen GS, Ahmad R, Zhang SS, Zhang Y, Kan J, Dong L, Wang ZY, Zhao FX, Zhao JD. Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study. World J Clin Cases 2018; 6(10): 373-383
URL http://www.wjgnet.com/2307-8960/full/v6/i10/373.htm
DOI http://dx.doi.org/10.12998/wjcc.v6.i10.373
Full Article (PDF) WJCC-6-373.pdf
Full Article (Word) WJCC-6-373.doc